Skip to main content
OpenTrials

Clinical trial condition

Lung Diseases, Obstructive

Explore clinical trials studying Lung Diseases, Obstructive. Study availability and eligibility vary by location and protocol.

7,989 public trials 745 recruiting studies
Refine in advanced search Browse all conditions

Lung Diseases, Obstructive trial results

Completed

Changes in Inflammatory Markers During Pulmonary Rehabilitation Based on Exacerbation States in COPD

NCT02740686

Conditions
Behavior, Chronic Disease, Chronic Obstructive Pulmonary Disease, +9 more
Locations
  • Lindum Medical Practice Lincoln, Lincolnshire, United Kingdom
  • Nettleham Medical Practice Lincoln, Lincolnshire, United Kingdom
  • Welton Surgery Lincoln, Lincolnshire, United Kingdom
  • Birchwood Medical Practice Lincoln, Lincolnshire, United Kingdom
View Trial Details
Completed

Investigate the Impact of Early Treatment Initiation With Tiotropium in Patients Recovering From Hospitalization for an Acute COPD Exacerbation 2

NCT01662986

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • 205.478.00243 Boehringer Ingelheim Investigational Site Montgomery, Alabama, United States
  • 205.478.00208 Boehringer Ingelheim Investigational Site Flagstaff, Arizona, United States
  • 205.478.00260 Boehringer Ingelheim Investigational Site Glendale, Arizona, United States
  • 205.478.00241 Boehringer Ingelheim Investigational Site Loma Linda, California, United States
View all 50 locations
View Trial Details
Completed

Investigate the Impact of Early Treatment Initiation With Tiotropium in Patients Recovering From Hospitalization for an Acute COPD Exacerbation 1

NCT01663987

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • 205.477.001039 Boehringer Ingelheim Investigational Site Birmingham, Alabama, United States
  • 205.477.001050 Boehringer Ingelheim Investigational Site Birmingham, Alabama, United States
  • 205.477.001021 Boehringer Ingelheim Investigational Site Florence, Alabama, United States
  • 205.477.001046 Boehringer Ingelheim Investigational Site Fountain Valley, California, United States
View all 50 locations
View Trial Details
Completed

A Phase II, Study To Evaluate The Efficacy And Safety Of PH-797804 In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD).

NCT00559910

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +6 more
Locations
  • Pfizer Investigational Site La Plata, Buenos Aires, Argentina
  • Pfizer Investigational Site Buenos Aires, Buenos Aires F.D., Argentina
  • Pfizer Investigational Site Buenos Aires, Buenos Aires F.D., Argentina
  • Pfizer Investigational Site Ciudad Autonoma de Buenos Aires (caba), Buenos Aires F.D., Argentina
View all 45 locations
View Trial Details
Completed

Preference Attributes of ELLIPTA Dry Powder Inhaler (DPI) and HANDIHALER DPI in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

NCT02786927

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • GSK Investigational Site Glendale, Arizona, United States
  • GSK Investigational Site Clearwater, Florida, United States
  • GSK Investigational Site Orlando, Florida, United States
  • GSK Investigational Site Tampa, Florida, United States
View all 22 locations
View Trial Details

Related conditions